Antengene, ATG-207, Autoimmune Diseases, T Cell Therapy, Bifunctional Fusion Protein, TGF-β, CD3 Targeting, Regulatory T Cells, Immunology Research, Preclinical Research, Systemic Lupus Erythematosus

Shanghai and Hong Kong, China, October 9, 2026 Antengene Corporation Limited has announced that it will present new preclinical...